We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+18.9%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.8B
AUM Growth
+$824M
Cap. Flow
+$356M
Cap. Flow %
9.35%
Top 10 Hldgs %
43.5%
Holding
460
New
148
Increased
43
Reduced
126
Closed
97

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$342M
2
MRUS
Merus
MRUS
+$152M
3
COOP
Mr. Cooper
COOP
+$123M
4
AVDX
AvidXchange
AVDX
+$85.1M
5
ETNB
89bio
ETNB
+$82.9M

Sector Composition

Rank Sector Weight
1 Financials 33.45%
2 Technology 18.96%
3 Healthcare 16.01%
4 Industrials 6.99%
5 Communication Services 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAY
1
DELISTED
Dayforce
DAY
$313M 8.24%
4,530,530
+3,962,795
+698% +$273M
CYBR
2
DELISTED
CyberArk
CYBR
$238M 6.25%
533,085
+192,644
+57% +$92.7M
RNAM
3
DELISTED
Avidity Biosciences
RNAM
$178M 4.68%
+2,467,139
New +$159M
EXAS
4
DELISTED
Exact Sciences
EXAS
$175M 4.61%
+1,725,000
New +$139M
AL
5
DELISTED
Air Lease Corp
AL
$155M 4.08%
2,414,969
+2,236,473
+1,253% +$143M
CMA
6
DELISTED
Comerica
CMA
$151M 3.96%
+1,733,438
New +$140M
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$144M 3.78%
+650,191
New +$105M
BHF icon
8
Brighthouse Financial
BHF
$3.62B
$113M 2.98%
+1,747,986
New +$103M
EA icon
9
Electronic Arts
EA
$52.4B
$104M 2.72%
506,694
+426,494
+532% +$86.1M
CADE
10
DELISTED
Cadence Bank
CADE
$84M 2.21%
+1,959,734
New +$77.6M
CWAN
11
DELISTED
Clearwater Analytics
CWAN
$75.8M 1.99%
+3,144,529
New +$63M
SEE
12
DELISTED
Sealed Air
SEE
$58M 1.53%
+1,400,000
New +$54.2M
ATXS
13
DELISTED
Astria Therapeutics
ATXS
$49.4M 1.3%
+3,776,154
New +$45.1M
CFLT
14
DELISTED
Confluent
CFLT
$42M 1.1%
+1,388,508
New +$34.1M
AHL
15
DELISTED
Aspen Insurance
AHL
$41.7M 1.1%
1,123,495
+203,101
+22% +$7.49M
HI
16
DELISTED
Hillenbrand
HI
$37.8M 0.99%
+1,192,320
New +$36.7M
PLYM
17
DELISTED
Plymouth Industrial REIT
PLYM
$36.4M 0.96%
+1,662,651
New +$36.5M
FYBR
18
DELISTED
Frontier Communications
FYBR
$27.7M 0.73%
+727,844
New +$27.5M
HOLX
19
DELISTED
Hologic
HOLX
$27.4M 0.72%
+368,378
New +$26.9M
DENN
20
DELISTED
Denny's
DENN
$24.1M 0.63%
+3,877,778
New +$22M
DMII
21
Drugs Made In America Acquisition II Corp
DMII
$643M
$23.3M 0.61%
+2,349,899
New +$23.2M
FOLD
22
DELISTED
Amicus Therapeutics
FOLD
$22.8M 0.6%
+1,603,788
New +$15.8M
EVAC
23
EQV Ventures Acquisition Corp II
EVAC
$597M
$22.2M 0.58%
2,210,096
-13,433
-0.6% -$134K
GIW
24
GigCapital8
GIW
$368M
$21.5M 0.57%
+2,175,283
New +$21.6M
JHG
25
DELISTED
Janus Henderson
JHG
$21.4M 0.56%
+449,055
New +$19.9M

Similar funds

Glazer Capital LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Glazer Capital LLC held 460 positions worth $3.8B, up 28% from $2.98B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Glazer Capital LLC deployed $356M of net new capital in Q4 2025, opening 148 new positions and adding to 43 existing holdings. Its largest new stake was Avidity Biosciences: 2,467,139 shares worth $178M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was ProAssurance, an estimated $19M trimmed.

  • Glazer Capital LLC's largest Q4 2025 buy was Avidity Biosciences: 2,467,139 shares worth $178M.
  • Glazer Capital LLC added most to Dayforce in Q4 2025, an estimated $273M increase.
  • Glazer Capital LLC's biggest Q4 2025 reduction was ProAssurance, cutting an estimated $19M.
  • Glazer Capital LLC fully exited Verona Pharma in Q4 2025, selling an estimated $342M.
  • Glazer Capital LLC's ten largest holdings make up 44% of its $3.8B portfolio in Q4 2025.
  • Glazer Capital LLC opened 148 new positions and closed 97 in Q4 2025.
  • Glazer Capital LLC's portfolio value rose 28% quarter-over-quarter to $3.8B.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.